Ancient syrup could be key to ICU recovery
NCT ID NCT07157748
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether a traditional Chinese medicine called Compound Ejiao Syrup can improve exercise tolerance and quality of life in patients who have recently left the ICU. About 156 critically ill adults will receive either the syrup or a placebo for 90 days. The main goal is to see if they can walk farther in six minutes, with additional checks on physical function and well-being.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Compound Ejiao Syrup (a traditional Chinese medicine oral solution)
What this could lead to
If it works, this could offer a simple, low-cost way to help ICU survivors recover faster and feel better.
What could go wrong
This is an early-stage trial with only 156 patients, and the syrup's benefits are unproven. It may not outperform a placebo, and individual results may vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICALLY-ILL PATIENTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
the Southwest hospital
Chongqing, Chongqing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
Contact
Contact